TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27215948

Group type: EXPERIMENTAL
Intervention: Feldenkrais method
Number of subjects: 53

Group type: COMPARATOR
Intervention: Back School
Number of subjects: 53
Study: 25772065

Group type: EXPERIMENTAL
Intervention: Multi-screen (television + iPad + smartphone)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Single-screen (television)
Number of subjects: 78
Study: 23649042

Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate (20 mg, twice daily for 2 years)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 45
Study: 21838909

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (ASAQ)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 366
Study: 19707085

Group type: EXPERIMENTAL
Intervention: Isolated telephone interventions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 8
Study: 18268858

Group type: EXPERIMENTAL
Intervention: Transilluminated powered phlebectomy (TIPP) using local tumescent anaesthesia (TA)
Number of subjects: 20
Study: 15950714

Group type: EXPERIMENTAL
Intervention: Immediate antiepileptic drug treatment
Number of subjects: 1847

Group type: COMPARATOR
Intervention: Deferred antiepileptic drug treatment
Number of subjects: 1847
Study: 11790928

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ACE-I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers (BB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II antagonists (AII-a)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional antiarrhythmic drug therapy (ADT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable defibrillators (ICD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BP)
Number of subjects: 0
Study: 10216073

Group type: EXPERIMENTAL
Intervention: rhTPO and G‐CSF
Number of subjects: 29

Group type: COMPARATOR
Intervention: G‐CSF alone
Number of subjects: 29
Study: 8682055

Group type: EXPERIMENTAL
Intervention: Spironolactone (12.5, 25, 50, or 75 mg per day)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1400
Study: 2184556

Group type: EXPERIMENTAL
Intervention: 50 mg atenolol (Tenormin)
Number of subjects: 292

Group type: COMPARATOR
Intervention: 50 mg atenolol and 12.5 mg chlorthalidone (Tenoretic Mite)
Number of subjects: 292
Study: 376390

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg daily for 1 year maintenance therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 21
Study: 31688650

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) supplementation
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Nonuser group (Control)
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for FO users
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for nonusers
Number of subjects: 1635
Study: 31081565

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis symptoms in the past year at 6.5 years
Number of subjects: 13889

Group type: EXPERIMENTAL
Intervention: Asthma symptoms in the past year at 6.5 years
Number of subjects: 13889

Group type: COMPARATOR
Intervention: Physician-diagnosed atopic dermatitis in the first year of life
Number of subjects: 13889
Study: 29034644

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic Acid (EPA) 2 g/day for 8 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 25935076

Group type: EXPERIMENTAL
Intervention: CwSCD
Number of subjects: 0

Group type: COMPARATOR
Intervention: CwTLD
Number of subjects: 0
Study: 22269963

Group type: EXPERIMENTAL
Intervention: High saturated fatty acid (SFA) diet
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: High monounsaturated fatty acid (MUFA) diet
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Low-fat-high-n3 polyunsaturated fatty acid (PUFA) diet
Number of subjects: 486
Study: 22072036

Group type: EXPERIMENTAL
Intervention: Mobile safety street (MSS) experience
Number of subjects: 1692

Group type: COMPARATOR
Intervention: Traditional classroom safety curriculum
Number of subjects: 1692
Study: 19143697

Group type: EXPERIMENTAL
Intervention: Airway Scope
Number of subjects: 20

Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 20
Study: 17061961

Group type: EXPERIMENTAL
Intervention: Zolpidem-MR 6.25 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zolpidem-MR 12.5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Flurazepam 30 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 15301630

Group type: EXPERIMENTAL
Intervention: Intrinsic goals (community, personal growth, health) presented in an autonomy-supportive manner
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extrinsic goals (money, image) presented in a controlling manner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrinsic goals and autonomy support combined
Number of subjects: 0
Study: 11848519

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin-based chemotherapy and irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyurea plus irradiation or irradiation alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by radical hysterectomy
Number of subjects: 0
Study: 9422299

Group type: EXPERIMENTAL
Intervention: 2xED95 cisatracurium
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4xED95 cisatracurium
Number of subjects: 24
Study: 8342825

Group type: EXPERIMENTAL
Intervention: 5 mg/kg of 2.5% thiopental
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.7 g/kg alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 3689105

Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine in saline
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Papaverine with phentolamine mesylate in saline
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 11
Study: 31538887

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Combination of mitiglinide and voglibose
Number of subjects: 12
Study: 30367991

Group type: EXPERIMENTAL
Intervention: PGx + arm (results received at baseline)
Number of subjects: 408

Group type: COMPARATOR
Intervention: PGx - arm (results received after 12 months)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: PGx + arm
Number of subjects: 408

Group type: COMPARATOR
Intervention: PGx - arm
Number of subjects: 408
Study: 26928118

Group type: EXPERIMENTAL
Intervention: Single-catheter approach with JL3.5
Number of subjects: 206

Group type: COMPARATOR
Intervention: Two-catheter approach with JL3.5 and right Judkins 4.0
Number of subjects: 206
Study: 24322509

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 40,000 IU
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 40
Study: 23221670

Group type: EXPERIMENTAL
Intervention: Device-assisted ultrasound-guided injection
Number of subjects: 33

Group type: COMPARATOR
Intervention: Palpation-guided injection
Number of subjects: 33
Study: 22047600

Group type: EXPERIMENTAL
Intervention: Thrive intervention program for family day care educators; delivered over 12 months including workshops, activity exchanges, and focused discussions.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal work practice (Control group); no intervention activities during the initial 15 months.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Thrive intervention program; assessed at baseline, 1 month, 6 months, and 12 months post-intervention.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Thrive intervention program; process evaluation at 1 month, 6 months, and 12 months post-intervention.
Number of subjects: 70
Study: 18062845

Group type: COMPARATOR
Intervention: OROS hydromorphone 16 mg with 0% alcohol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 4% alcohol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 20% alcohol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 40% alcohol
Number of subjects: 24
Study: 16432681

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Topiramate 25 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Topiramate (both doses)
Number of subjects: 12
Study: 12606507

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study: 10690661

Group type: EXPERIMENTAL
Intervention: alpha-tricalcium-phosphate-containing chewing gum (2.5% mass fraction)
Number of subjects: 14

Group type: COMPARATOR
Intervention: conventional sugar-free gum (control)
Number of subjects: 14
Study: 9212477

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 32

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 32
Study: 8401959

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Supportive listening
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Psychotherapy (post-trial)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (declined psychotherapy)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Psychotherapy (one year follow-up)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Dropped out of trial
Number of subjects: 102
Study: 3147046

Group type: EXPERIMENTAL
Intervention: Nalmefene (opioid antagonist)
Number of subjects: 11
Study: 31929371

Group type: EXPERIMENTAL
Intervention: IgAN patients
Number of subjects: 394
Study: 30376880

Group type: COMPARATOR
Intervention: Bordered polyurethane dressing (BPU, standard care)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Integrated securement device (ISD)
Number of subjects: 300
Study: 27070681

Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard preconsultation material
Number of subjects: 16
Study: 24016403

Group type: COMPARATOR
Intervention: Conventional Manual Wheelchair (CMW)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ergonomic Hand Drive Mechanism (EHDM)
Number of subjects: 12
Study: 24325639

Group type: EXPERIMENTAL
Intervention: Near-peer teaching course
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional clinical examination course
Number of subjects: 84
Study: 20493427

Group type: EXPERIMENTAL
Intervention: ESR measurement at 15 min
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ESR measurement at 30 min
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ESR measurement at 60 min
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Correlation between 15 min and 60 min ESR measurements
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Correlation between 30 min and 60 min ESR measurements
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Prediction of 60 min ESR based on 30 min ESR
Number of subjects: 220
Study: 18981464

Group type: EXPERIMENTAL
Intervention: Letrozole (Let)
Number of subjects: 2685

Group type: COMPARATOR
Intervention: Tamoxifen (Tam)
Number of subjects: 2685
Study: 17125606

Group type: EXPERIMENTAL
Intervention: Foscarnet sodium
Number of subjects: 208

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 208
Study: 14691382

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Behavioral anger
Number of subjects: 300
Study: 10589000

Group type: EXPERIMENTAL
Intervention: Salmeterol powder
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 7574933

Group type: EXPERIMENTAL
Intervention: Reactive patients (DTH response present)
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Anergic patients (DTH response absent)
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Antibody response to protein antigens
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Antibody response to polysaccharide antigens
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: T cell presence in skin (measured by mRNA signal CD3)
Number of subjects: 4292

Group type: COMPARATOR
Intervention: Circulating and exudate polymorphonuclear cell function
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Parental nutrition in anergic patients
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Overall patient mortality
Number of subjects: 4292

Group type: EXPERIMENTAL
Intervention: Reduced DTH response
Number of subjects: 4292
Study: 2009043

Group type: EXPERIMENTAL
Intervention: Magnetotherapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (hot pack applications and passive manual stretching and pulley exercises)
Number of subjects: 47
Study: 6110965

Group type: EXPERIMENTAL
Intervention: Intrarectal metronidazole
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Intraincisional povidone iodine
Number of subjects: 496

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 496
Study: 30964435

Group type: EXPERIMENTAL
Intervention: WhatsApp group
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 27436026

Group type: EXPERIMENTAL
Intervention: Model A (diabetes mellitus, history of urological/nephrological disease, cardiovascular disease, hypertension)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Model B (diabetes mellitus, history of urological/nephrological disease, age >75 years, congestive heart failure)
Number of subjects: 1001
Study: 25559870

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: air-Q SP
Number of subjects: 80
Study: 23994882

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN) 20 mg retarded release orally twice per day, n=30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo, n=30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of ISMN vs. placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 22314980

Group type: EXPERIMENTAL
Intervention: 500ml of water
Number of subjects: 37
Study: 19263918

Group type: EXPERIMENTAL
Intervention: Videophone counseling sessions
Number of subjects: 35

Group type: COMPARATOR
Intervention: Telephone counseling sessions
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nurse visualization via videophone
Number of subjects: 35
Study: 16254590

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Timolol 0.5% twice daily
Number of subjects: 30
Study: 14769678

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 1865

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: Elevated creatine kinase-MB and troponins
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: Elevated high-sensitivity C-reactive protein and brain natriuretic peptide
Number of subjects: 1865
Study: 11694921

Group type: EXPERIMENTAL
Intervention: Group 1: ASD with removal of only an inferior clavicular osteophyte
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Group 2: Resection of any inferior clavicle spur, violation of the inferior joint capsule, and removal of articular cartilage to a level adjacent with the resected acromion
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Group 3: Complete distal clavicle excision
Number of subjects: 76
Study: 9400772

Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone (DMS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Topical 0.1% fluorometholone (FML)
Number of subjects: 16
Study: 7959158

Group type: EXPERIMENTAL
Intervention: Ultrasound only (Group I, N=96)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ultrasound plus estradiol (Group II, N=24)
Number of subjects: 120
Study: 2953865

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29943946

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone grafting (test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spontaneous healing (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 28196169

Group type: EXPERIMENTAL
Intervention: PRF + MCAF
Number of subjects: 20

Group type: COMPARATOR
Intervention: MCAF with SCTG
Number of subjects: 20
Study: 26385039

Group type: EXPERIMENTAL
Intervention: High-risk percutaneous coronary intervention (PCI)
Number of subjects: 184
Study: 24271093

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (CPT) for airway clearance
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nasotracheal suction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG) without respiratory diseases
Number of subjects: 24
Study: 21030369

Group type: EXPERIMENTAL
Intervention: Liquid captopril formulations
Number of subjects: 18

Group type: COMPARATOR
Intervention: Licensed tablet form
Number of subjects: 18
Study: 18441854

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1%-BPO 2.5% combination product
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1%-BPO 5% combination product
Number of subjects: 60

Group type: COMPARATOR
Intervention: BPO 2.5% monotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: BPO 5% monotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: BPO 10% monotherapy
Number of subjects: 60
Study: 16613208

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for early gastric cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery and endoscopic mucosal resection
Number of subjects: 0
Study: 12798618

Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a BCG scar
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a positive tuberculin test
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a BCG scar after censoring for TB exposure
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: BCG-vaccinated children with a positive tuberculin test after censoring for TB exposure
Number of subjects: 1813

Group type: COMPARATOR
Intervention: Children positive to tetanus or diphtheria in the skin test
Number of subjects: 1813
Study: 10780685

Group type: EXPERIMENTAL
Intervention: Patients with β-thalassemia
Number of subjects: 84

Group type: COMPARATOR
Intervention: Healthy persons (controls)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Patients with β-thalassemia and controls
Number of subjects: 84
Study: 10165114

Group type: EXPERIMENTAL
Intervention: Jet spacer device with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard actuator with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Number of subjects: 66
Study: 1675577

Group type: EXPERIMENTAL
Intervention: Atipamezole (6.7 micrograms kg-1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atipamezole (27 micrograms kg-1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atipamezole (67 micrograms kg-1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study: 6824894

Group type: EXPERIMENTAL
Intervention: Filter (0.2 micron filter with hydrophobic and hydrophilic elements)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Dummy (identical dummy without filtration)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Filter
Number of subjects: 194

Group type: COMPARATOR
Intervention: Dummy
Number of subjects: 194
Study: 29547019

Group type: EXPERIMENTAL
Intervention: Galvano-puncture (GG)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dermabrasion (DG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 48
Study: 29970026

Group type: EXPERIMENTAL
Intervention: Third model (including background variables, MAP, biomarkers, and mean Uta-PI)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Third model
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Second model (including background variables, MAP, and biomarkers)
Number of subjects: 257
Study: 27258294

Group type: EXPERIMENTAL
Intervention: Walking in a city park
Number of subjects: 20

Group type: COMPARATOR
Intervention: Walking in an urban street environment
Number of subjects: 20
Study: 24943285

Group type: EXPERIMENTAL
Intervention: BOLD+ diet (153 g beef per day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: HAD (20 g beef per day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BOLD diet (113 g beef per day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DASH diet (28 g beef per day)
Number of subjects: 36
Study: 22564271

Group type: EXPERIMENTAL
Intervention: High-level radiation from mobile phone (Experimental Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Maximum-level radiation from mobile phone (Experimental Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mobile phone turned off (Control Group)
Number of subjects: 30
Study: 20629812

Group type: EXPERIMENTAL
Intervention: Any medication change or therapeutic lifestyle changes counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational materials with telephone calls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational materials without telephone calls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Financial incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 18352900

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mL, 8 mg/2 mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 16181864

Group type: EXPERIMENTAL
Intervention: Cardiac subjects (CABG or PCI)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no coronary artery disease)
Number of subjects: 82